The global demand for Glucose Monitor Device Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020- 2026.
A blood glucose meter is a small, portable machine that's used to measure how much glucose (a type of sugar) is in the blood (also known as the blood glucose level). People with diabetes often use a blood glucose meter to help them manage their condition. It also help in preventing other related health conditions such as neuropathy, retinopathy, and cardiovascular diseases.
Rising prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. Moreover, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further fuelling the demand for blood glucose monitoring devices. However, high cost associated with the application of CGM systems is the key factor hampering the growth of this market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of glucose monitor device.
The entire glucose monitor device market has been sub-categorized into type, application, and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Self monitoring meter
- Continuous glucose Monitoring System
- Hospital and Clinic
- Diagnostic Centers
- home settings
This section covers regional segmentation which accentuates on current and future demand for glucose monitor device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Glucose monitor device Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the glucose monitor device market include Roche, DexCom, Inc., Johnson & Johnson, AstraZeneca plc, Insulet Corporation, Becton, Merck & Co., GlaxoSmithKline plc, Nova Biomedical Corporation, Dickinson & Company, Eli Lilly and Company, Lupin Limited, B. Braun Melsungen AG, Takeda Pharmaceutical Company Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.